COVID-19 in Pediatric Intensive Care Units in Poland, PAPITCO-19 Study (Polish Analysis of PICU Trends during

Maria Damps1, Elżbieta Byrska-Maciejasz2, Małgorzata Kowalska3

  • 1Department of Anaesthesiology and Intensive Care, Upper Silesian Child Health Centre, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland.

PubMed

Insights

Children with comorbidities face a higher risk of severe COVID-19. Respiratory failure, mechanical ventilation, and high AST levels indicate a poor prognosis in pediatric intensive care unit patients.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Respiratory medicine

Background:

  • COVID-19 affects children, with a small percentage requiring intensive care.
  • Comorbidities increase the risk of severe disease and respiratory failure in pediatric COVID-19 cases.

Purpose of the Study:

  • To analyze epidemiological and laboratory parameters of children admitted to pediatric intensive care units (PICUs) for severe SARS-CoV-2 infection.
  • To identify factors associated with mortality and prognosis in critically ill children with COVID-19.

Main Methods:

  • Retrospective multi-center study of children with confirmed SARS-CoV-2 admitted to PICUs (November 2020 - August 2021).
  • Analysis of epidemiological data, laboratory parameters, and outcomes (survival/death).
  • Utilized Lung Injury Score and Pediatric Sequential Organ Failure Assessment (pSOFA).

Main Results:

  • 45 pediatric patients analyzed; overall mortality was 40%.
  • Significant differences between survivors and non-survivors were observed in respiratory parameters.
  • Elevated AST levels correlated with disease severity (p=0.028).
  • Mechanical ventilation patients with better outcomes had higher initial oxygen index and lower pSOFA and AST levels.

Conclusions:

  • Comorbidities are a key risk factor for severe COVID-19 in children, mirroring adult trends.
  • Progressive respiratory failure, need for mechanical ventilation, and persistently high AST levels are poor prognostic indicators.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
284
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
278
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
253
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
285
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
232
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
169